SI9620099A - Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A - Google Patents

Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A Download PDF

Info

Publication number
SI9620099A
SI9620099A SI9620099A SI9620099A SI9620099A SI 9620099 A SI9620099 A SI 9620099A SI 9620099 A SI9620099 A SI 9620099A SI 9620099 A SI9620099 A SI 9620099A SI 9620099 A SI9620099 A SI 9620099A
Authority
SI
Slovenia
Prior art keywords
alkyl
aryl
cycloalkyl
aralkyl
substituted
Prior art date
Application number
SI9620099A
Other languages
English (en)
Slovenian (sl)
Inventor
Hartmuth Christian Kolb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI9620099A publication Critical patent/SI9620099A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/207Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
SI9620099A 1995-06-29 1996-06-26 Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A SI9620099A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH191495 1995-06-29
PCT/EP1996/002785 WO1997001569A1 (en) 1995-06-29 1996-06-26 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a

Publications (1)

Publication Number Publication Date
SI9620099A true SI9620099A (sl) 1998-08-31

Family

ID=4221546

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9620099A SI9620099A (sl) 1995-06-29 1996-06-26 Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A

Country Status (19)

Country Link
EP (1) EP0836610A1 (zh)
JP (1) JPH11508548A (zh)
KR (1) KR19990028543A (zh)
CN (1) CN1196731A (zh)
AU (1) AU707474B2 (zh)
BR (1) BR9609285A (zh)
CA (1) CA2224346A1 (zh)
CZ (1) CZ419797A3 (zh)
EA (1) EA001356B1 (zh)
HU (1) HUP9801805A3 (zh)
IL (1) IL118740A0 (zh)
MX (1) MX9800218A (zh)
NO (1) NO976065L (zh)
NZ (1) NZ311686A (zh)
PL (1) PL324258A1 (zh)
SI (1) SI9620099A (zh)
SK (1) SK177897A3 (zh)
TR (1) TR199701728T1 (zh)
WO (1) WO1997001569A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002217999A1 (en) 2000-11-01 2002-05-15 Cor Therapeutics, Inc. Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
CN103626813B (zh) * 2005-09-02 2017-05-03 糖模拟物有限公司 异型双功能全选择素抑制剂
EP1764093A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764096A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764095A1 (en) 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
JP5298020B2 (ja) * 2006-10-12 2013-09-25 グリコミメティクス, インコーポレイテッド ヘキソースおよびn−アセチルヘキソサミンの糖模倣体置換
CA2677747A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
US9109002B2 (en) 2011-12-22 2015-08-18 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
ES2668045T3 (es) 2012-12-07 2018-05-16 Glycomimetics, Inc. Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
EP3227310B1 (en) 2014-12-03 2019-07-31 GlycoMimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
WO2018031445A1 (en) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
JP7069136B2 (ja) 2016-10-07 2022-05-17 グリコミメティクス, インコーポレイテッド 極めて強力な多量体e-セレクチンアンタゴニスト
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
WO2019133878A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
CA2100412A1 (en) * 1992-07-15 1994-01-16 Yutaka Yamada Glycolipid derivatives

Also Published As

Publication number Publication date
SK177897A3 (en) 1998-08-05
EA199800103A1 (ru) 1998-08-27
TR199701728T1 (xx) 1998-03-21
HUP9801805A3 (en) 2002-01-28
CA2224346A1 (en) 1997-01-16
CZ419797A3 (cs) 1998-06-17
AU6305396A (en) 1997-01-30
KR19990028543A (ko) 1999-04-15
AU707474B2 (en) 1999-07-08
PL324258A1 (en) 1998-05-11
HUP9801805A2 (hu) 1998-12-28
EP0836610A1 (en) 1998-04-22
WO1997001569A1 (en) 1997-01-16
IL118740A0 (en) 1996-10-16
NO976065D0 (no) 1997-12-23
NZ311686A (en) 2000-01-28
MX9800218A (es) 1998-07-31
BR9609285A (pt) 1999-05-11
CN1196731A (zh) 1998-10-21
EA001356B1 (ru) 2001-02-26
NO976065L (no) 1998-02-17
JPH11508548A (ja) 1999-07-27

Similar Documents

Publication Publication Date Title
SI9620099A (sl) Diglikozilirani 1,2-dioli kot mimetiki sialil-Lewis X in sialil-Lewis A
KR20000029862A (ko) 개질올리고당
US7037899B2 (en) Derivatives of monosaccharides as cell adhesion inhibitors
DE3508356C2 (zh)
EP0063489B1 (en) 4"-modified methylene oleandomycins
DE10013328C2 (de) Verfahren zur Herstellung von perbenzylierten 1-O-Glycosiden
RU2065863C1 (ru) Производные дезацетилколхицина, способ их получения и противоопухолевая композиция
EP0277310A1 (de) Zytostatisch wirksame Anthracyclinderivate
US5034380A (en) Alkoxymethylidene epipodophyllotoxin glucosides
SU961354A1 (ru) 3-Фтор-2,3-дидезоксиаденозин,про вл ющий цитостатическую активность
HU217114B (hu) Új monoszacharidszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására
JPH0560474B2 (zh)
JPS61243096A (ja) シアル酸誘導体及びその製造方法
JPH0393791A (ja) ケトホスフアミド配糖体類、それらの製造方法および薬活性化合物類としてのそれらの使用
EP1397376B1 (de) Verfahren zur herstellung von perbenzylierten 1-o-glycosiden
DE10129677C2 (de) Verfahren zur Herstellung von perbenzylierten 1-O-Glycosiden
JPS6310717B2 (zh)
JPS58198497A (ja) 新規アミノ配糖体及びその製法
CA2433856A1 (en) Alkylated inositolglycans and their use
EP1404691A2 (de) Verfahren zur herstellung von peracylierten 1-o-glycosiden
CS241099B2 (cs) Způsob přípravy 4“-epi-9-deoxo-9a-methyl-9a-aza- -9a-bomoerythromycinu A
JPS6310713B2 (zh)